Resolution of marked intrapartum fetal tachycardia following intravenous nalbuphine hydrochloride.
We report a case of a patient who received nalbuphine during labor. The fetus was in an awake state, but when exposed to intravenous nalbuphine manifested quiet sleep. This suggest a physiological response and not a sign of fetal compromise.
Sherer
D M
DM
Department of Obstetrics & Gynecology, Strong Memorial Hospital, University of Rochester School of Medicine and Dentistry, New York.
Cooper
E M
EM
Spoor
C
C
Serletti
B L
BL
Woods
J R
JR
D000293:Adolescent; D016362:Analgesia, Obstetrical; D005260:Female; D005324:Fetal Movement / Q000187:drug effects; D006340:Heart Rate, Fetal / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D009266:Nalbuphine / Q000627:therapeutic use*; D011247:Pregnancy
D009266:Nalbuphine